PROKIDNEY CORP. — Director's Dealing 2023

Aug 3, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PROKIDNEY CORP. (PROK)
CIK: 0001850270
Period of Report: 2023-08-01

Reporting Person: Culleton Bruce (EVP, Clinical Development)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2023-08-01	Employee stock option (right to buy)	$13.08	A	485000	Acquired	2033-08-01	Class A Ordinary Shares (485000)	Direct

Footnotes

F1: The option vests 25% on 1st anniversary of August 1, 2023 and the remaining 75% vests in substantially equal monthly installments for 36 months thereafter.